1. Abell E, Morgan K. The treatment of idiopathic hyperhidrosis by glycopyrronium bromide and tap water iontophoresis. Br J Dermatol. 1974;91:87-91.

2. Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis and its surgical treatment: a report of 100 cases. Ann Surg. 1977;186:34-41.

3. Akins DL, Meisenheimer JL, Dobson RL. Efficacy of the Drionic unit in the treatment of hyperhidrosis. J Am Acad Dermatol. 1987;16:828-832.

4. Altman RS, Schwartz RA. Emotionally induced hyperhidrosis. Cutis. 2002;69:336-338.

5. Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci. 2000;37:25-31.

6. Andrews BT, Rennie JA. Predicting changes in the distribution of sweating following thoracoscopic sympathectomy. Br J Surg. 1997;84:1702-1704.

7. Anliker MD, Kreyden OP. Tap water iontophoresis. Curr Probl Dermatol. 2002;30:48-56.

8. Aoki KR. Physiology and pharmacology of therapeutic botulinum neurotoxins. Curr Probl Dermatol. 2002;30:107-116.

9. Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast Reconstr Surg. 2002;110:222-228.

10. Atkinson JL, Feeley RD. Sympathotomy instead of sympathectomy for palmar hyperhidrosis: minimizing postoperative compensatory hyperhidrosis. Mayo Clin Proc. 2003;78:167-172.

11. Baumann LS, Halem ML. Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol. 2003;139:226-227.

12. Beerens AJ, Snow GB. Botulinum toxin A in the treatment of patients with Frey syndrome. Br J Surg. 2002;89:116-119.

13. Belin EE, Polo J. Treatment of compensatory hyperhidrosis with botulinum toxin type A. Cutis. 2003;71:68-70.

14. Benohanian A, Dansereau A, Bolduc C, Bloom E. Localized hyperhidrosis treated with aluminum chloride in a salicylic acid gel base. Int J Dermatol. 1998;37:701-703.

15. Bergstresser PR, Quero R. Treatment of hyperhidrosis with topical methenamine. Int J Dermatol. 1976;15:452-455.

16. Birner P, Heinzl H, Schindl M, Pumprla J, Schnider P. Cardiac autonomic function in patients suffering from primary focal hyperhidrosis. Eur Neurol. 2000;44:112-116.

17. Black MJ, Gunn A. The management of Frey's syndrome with aluminium chloride hexahydrate antiperspirant. Ann R Coll Surg Engl. 1990;72:49-52.

18. Blaheta HJ, Deusch H, Rassner G, Vollert B. Intravenous regional anesthesia (Bier's block) is superior to a peripheral nerve block for painless treatment of plantar hyperhidrosis with botulinum toxin. J Am Acad Dermatol. 2003;48:302-304.

19. Böni R. Generalized hyperhidrosis and its systemic treatment. Curr Probl Dermatol. 2002;30:44-47.

20. Botox prescribing information. Irvine, Calif: Allergan Inc; 2002.

21. Botox Cosmetic prescribing information. Irvine, Calif: Allergan Inc; 2002.

22. Bouman HD, Grunewald Lentzer EM. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phys Med. 1952;31:158-169.

23. Brandrup F, Larsen PO. Axillary hyperhidrosis: local treatment with aluminum chloride hexahydrate 25% in absolute ethanol. Acta Derm Venereol. 1978;58:461-465.

24. Bushara KO, Park DM. Botulinum toxin and sweating. J Neurol Neurosurg Psychiatry. 1994;57:1437-1438.

25. Canaday BR, Stanford RH. Propantheline bromide in the management of hyperhidrosis associated with spinal cord injury. Ann Pharmacother. 1995;29:489-492.

26. Chen HJ, Lu K, Liang CL. Transthoracic endoscopic T-2, 3 sympathectomy for facial hyperhidrosis. Auton Neurosci. 2001;93:91-94.

27. Chuang KS, Liu JC. Long-term assessment of percutaneous stereotactic thermocoagulation of upper thoracic ganglionectomy and sympathectomy for palmar and craniofacial hyperhidrosis in 1742 cases. Neurosurgery. 2002;5:963-969.

28. Cina CS, Clase CM. The Illness Intrusiveness Rating Scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res. 1999;8:693-698.

29. Collin J, Whatling P. Treating hyperhidrosis. Surgery and botulinum toxin are treatments of choice in severe cases. BMJ. 2000;320:1221-1222.

30. Cullen SI. Topical methenamine therapy for hyperhidrosis. Arch Dermatol. 1975;111:1158-1160.

31. Dahl JC, Glent-Madsen L. Treatment of hyperhidrosis manuum by tap water iontophoresis. Acta Derm Venereol. 1989;69:346-348.

32. Davidson JR, Foa EB, Connor KM, Churchill LE. Hyperhidrosis in social anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:1327-1331.

33. de Almeida AR, Kadunc BV, de Oliveira EM. Improving botulinum toxin therapy for palmar hyperhidrosis: wrist block and technical considerations. Dermatol Surg. 2001;27:34-36.

34. Dobson RL. Treatment of hyperhidrosis. Arch Dermatol. 1987;123:883-884.

35. Drott C, Gothberg G, Claes G. Endoscopic transthoracic sympathectomy: an efficient and safe method for the treatment of hyperhidrosis. J Am Acad Dermatol. 1995;33:78-81.

36. Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry. 1995;56:35.

37. Frankland JC, Seville RH. The treatment of hyperhidrosis with topical propantheline—a new technique. Br J Dermatol. 1971;85:577-581.

38. Fujita M, Mann T, Mann O, Berg D. Surgical pearl: use of nerve blocks for botulinum toxin treatment of palmar-plantar hyperhidrosis. J Am Acad Dermatol. 2001;45:587-589.

39. Garber A, Gregory RJ. Benztropine in the treatment of venlafaxine-induced sweating. J Clin Psychiatry. 1997;58:176-177.

40. Geiges ML. The history of botulism. Curr Probl Dermatol. 2002;30:77-93.

41. Glent-Madsen L, Dahl JC. Axillary hyperhidrosis. Local treatment with aluminium-chloride hexahydrate 25% in absolute ethanol with and without supplementary treatment with triethanolamine. Acta Derm Venereol. 1988;68:87-89.

42. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis. No sweat Botox. Dermatol Surg. 1998;24:817-819.

43. Glogau RG. Treatment of palmar hyperhidrosis with botulinum toxin. Semin Cutan Med Surg. 2001;20:101-108.

44. Goh CL. Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment. Int J Dermatol. 1990;29:368-370.

45. Goodman G. Diffusion and short-term efficacy of botulinum toxin a after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis. Dermatol Surg. 2003;29:533-538.

46. Gossot D, Galetta D, Pascal A, et al. Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg. 2003;75:1075-1079.

47. Grice K, Sattar H, Baker H. Treatment of idiopathic hyperhidrosis with iontophoresis of tap water and poldine methosulphate. Br J Dermatol. 1972;86:72-78.

48. Groscurth P. Anatomy of sweat glands. Curr Probl Dermatol. 2002;30:1-9.

49. Hafner J, Beer GM. Axillary sweat gland excision. Curr Probl Dermatol. 2002;30:57-63.

50. Heckmann M. Complications in patients with palmar hyperhidrosis treated with transthoracic endoscopic sympathectomy. Neurosurgery. 1998;42:1403-1404.

51. Heckmann M. Hyperhidrosis of the axilla. Curr Probl Dermatol. 2002;30:149-155.

52. Heckmann M, Breit S, Ceballos-Baumann A, Schaller M, Plewig G. Side-controlled intradermal injection of botulinum toxin A in recalcitrant axillary hyperhidrosis. J Am Acad Dermatol. 1999;41:987-990.

53. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med. 2001;344:488-493.

54. Heckmann M, Schaller M, Breit S, Plewig G. Evaluation of therapeutic success of hyperhidrosis therapy. Arch Dermatol. 2001;137:94.

55. Herbst F, Plas EG, Fugger R, Fritsch A. Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbs. A critical analysis and long-term results of 480 operations. Ann Surg. 1994;220:86-90.

56. Hill AC, Baker GF, Jansen GT. Mechanism of action of iontophoresis in the treatment of palmar hyperhidrosis. Cutis. 1981;28:69-70,72.

57. Hölzle E. Pathophysiology of sweating. Curr Probl Dermatol. 2002;30:10-22.

58. Hölzle E. Topical pharmacological treatment. Curr Probl Dermatol. 2002;30:30-43.

59. Hölzle E, Braun-Falco O. Structural changes in axillary eccrine glands following long-term treatment with aluminium chloride hexahydrate solution. Br J Dermatol. 1984;110:399-403.

60. Hsu CP, Shia SE, Hsia JY, Chuang CY, Chen CY. Experiences in thoracoscopic sympathectomy for axillary hyperhidrosis and osmidrosis: focusing on the extent of sympathectomy. Arch Surg. 2001;136:1115-1117.

61. Huang W, Foster JA, Rogachefsky AS. Pharmacology of botulinum toxin. J Am Acad Dermatol. 2000;43:249-259.

62. Huh CH, Han KH, Seo KI, Eun HC. Botulinum toxin treatment for a compensatory hyperhidrosis subsequent to an upper thoracic sympathectomy. J Dermatolog Treat. 2002;13:91-93.

63. Hund M, Kinkelin I, Naumann M, Hamm H. Definition of axillary hyperhidrosis by gravimetric assessment. Arch Dermatol. 2002;138:539-541.

64. Imhof M, Zacherl J, Plas EG, Herbst F, Jakesz R, Fugger R. Long-term results of 45 thoracoscopic sympathicotomies for primary hyperhidrosis in children. J Pediatr Surg. 1999;34:1839-1842.

65. Iwase S, Ikeda T, Kitazawa H, Hakusui S, Sugenoya J, Mano T. Altered response in cutaneous sympathetic outflow to mental and thermal stimuli in primary palmoplantar hyperhidrosis. J Auton Nerv Syst. 1997;64:65-73.

66. James WD, Schoomaker EB, Rodman OG. Emotional eccrine sweating. A heritable disorder. Arch Dermatol. 1987;123:925-929.

67. Juhlin L, Evers H, Broberg F. Inhibition of hyperhidrosis by topical application of a local anesthetic composition. Acta Derm Venereol. 1979;59:556-559.

68. Juhlin L, Hansson H. Topical glutaraldehyde for plantar hyperhidrosis. Arch Dermatol. 1968;97:327-330.

69. Kao MC, Chen YL, Lin JY, Hsieh CS, Tsai JC. Endoscopic sympathectomy treatment for craniofacial hyperhidrosis. Arch Surg. 1996;131:1091-1094.

70. Karakoç Y. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol. 2002;41:602-605.

71. Karamfilov T, Konrad H, Karte K, Wollina U. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase. Arch Dermatol. 2000;136:487-490.

72. Kestenholz PB, Weder W. Thoracic sympathectomy. Curr Probl Dermatol. 2002;30:64-76.

73. Khurana RK. Orthostatic hypotension-induced autonomic dysreflexia. Neurology. 1987;37:1221-1224.

74. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol. 2000;143:824-827.

75. Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Arch Dermatol. 2000;136:539-541.

76. Kreyden OP. Botulinum toxin: from poison to pharmaceutical. The history of a poison that became useful to mankind. Curr Probl Dermatol. 2002;30:94-100.

77. Kreyden OP. Rare forms of hyperhidrosis. Curr Probl Dermatol. 2002;30:178-187.

78. Kreyden OP, Schmid-Grendelmeier P, Burg G. Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature. Arch Dermatol. 2001;137:1622-1625.

79. Kuritzky A, Hering R, Goldhammer G, Bechar M. Clonidine treatment in paroxysmal localized hyperhidrosis. Arch Neurol. 1984;41:1210-1211.

80. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey syndrome) after intracutaneous injection of botulinum toxin type A: incidence, management, and outcome. Arch Otolaryngol Head Neck Surg. 1999;125:283-286.

81. Laccourreye O, Bonan B, Brasnu D, Laccourreye H. Treatment of Frey's syndrome with topical 2% diphemanil methylsulfate (Prantal): a double-blind evaluation of 15 patients. Laryngoscope. 1990;100:651-653.

82. Lai YT, Yang LH, Chio CC, Chen HH. Complications in patients with palmar hyperhidrosis treated with transthoracic endoscopic sympathectomy. Neurosurgery. 1997;41:110-113.

83. Laskawi R, Ellies M, Rodel R, Schoenebeck C. Gustatory sweating: clinical implications and etiologic aspects. J Oral Maxillofac Surg. 1999;57:642-648.

84. Laskawi R, Rohrbach S. Frey's syndrome. Treatment with botulinum toxin. Curr Probl Dermatol. 2002;30:170-177.

85. Levit F. Simple device for treatment of hyperhidrosis by iontophoresis. Arch Dermatol. 1968;98:505-507.

86. Levit F. Treatment of hyperhidrosis by tap water iontophoresis. Cutis. 1980;26:192-194.

87. LeWitt P. Hyperhidrosis and hypothermia responsive to oxybutynin. Neurology. 1988;38:506-507.

88. Lillis PJ, Coleman WP 3rd. Liposuction for treatment of axillary hyperhidrosis. Dermatol Clin. 1990;8:479-482.

89. Lin TS, Chou MC. Needlescopic thoracic sympathetic block by clipping for craniofacial hyperhidrosis: an analysis of 28 cases. Surg Endosc. 2002;16:1055-1058.

90. Lowe PL, Cerdan-Anz S, Lowe NJ. Botulinum toxin type a in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments. Dermatol Surg. 2003;29:545-548.

91. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg. 2002;28:822-827.

92. Luh JY, Blackwell TA. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate. South Med J. 2002;9:756-758.

93. Manca D, Valls-Sole J, Callejas MA. Excitability recovery curve of the sympathetic skin response in healthy volunteers and patients with palmar hyperhidrosis. Clin Neurophysiol. 2000;111:1767-1770.

94. Matthews BD, Bui HT, Harold KL, et al. Thoracoscopic sympathectomy for palmaris hyperhidrosis. South Med J. 2003;96:254-258.

95. Moraru E, Auff E, Schnider P. Hyperhidrosis of the palms and soles. Curr Probl Dermatol. 2002;30:156-169.

96. Myobloc prescribing information. South San Francisco, Calif: Elan Pharmaceuticals Inc; 2000.

97. Naumann M. Evidence-based medicine: botulinum toxin in focal hyperhidrosis. J Neurol. 2001;248(suppl 1):31-33.

98. Naumann M, Flachenecker P, Brocker EB, Toyka KV, Reiners K. Botulinum toxin for palmar hyperhidrosis. Lancet. 1997;34:252.

99. Naumann M, Hamm H. Treatment of axillary hyperhidrosis. Br J Surg. 2002;89:259-261.

100. Naumann MK, Hamm H, Lowe NJ. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial. Br J Dermatol. 2002;147:1218-1226.

101. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV, Reiners K. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301-304.

102. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ. 2001;323:596-599.

103. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. Arch Dermatol. 2003;139:731-736.

104. Noppen M, Sevens C, Gerlo E, Vincken W. Plasma catecholamine concentrations in essential hyperhidrosis and effects of thoracoscopic D2-D3 sympathicolysis. Eur J Clin Invest. 1997;27:202-205.

105. Odderson IR. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:480-483.

106. Orteu CH, McGregor JM, Almeyda JR, Rustin MH. Recurrence of hyperhidrosis after endoscopic transthoracic sympathectomy—case report and review of the literature. Clin Exp Dermatol. 1995;20:230-233.

107. Parslew R, Lewis-Jones MS. Localized unilateral hyperhidrosis secondary to an eccrine naevus. Clin Exp Dermatol. 1997;22:246-247.

108. Proebstle TM. Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg. 2002;28:1022-1026.

109. Rayner CR, Ritchie ID, Stark GP. Axillary hyperhidrosis, 20% aluminum chloride hexahydrate, and surgery. Br Med J. 1980;280:1168.

110. Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993;129:166-169.

111. Restivo DA, Lanza S, Patti F, et al. Improvement of diabetic autonomic gustatory sweating by botulinum toxin type A. Neurology. 2002;59:1971-1973.

112. Rex LO, Drott C, Claes G, Gothberg G, Dalman P. The Boras experience of endoscopic thoracic sympathicotomy for palmar, axillary, facial hyperhidrosis and facial blushing. Eur J Surg. 1998;580(suppl):23-26.

113. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis: evidence of genetic transmission. J Vasc Surg. 2002;35:382-386.

114. Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol. 2001;15:207-211.

115. Rossetto O, Seveso M, Caccin P, Montecucco C. Botulinum neurotoxins are metalloproteases specific for SNARE proteins involved in neuroexocytosis. Curr Probl Dermatol. 2002;30:117-125.

116. Ruchinskas RA. The relationship of psychopathology and hyperhidrosis. Br J Dermatol. 2002;147: 733-735.

117. Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study. Neurology. 2001;57:2095-2099.

118. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. I. Normal sweat gland function. J Am Acad Dermatol. 1989;20:537-563.

119. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol. 1989;20:713-726.

120. Sato K, Sato F. Sweat secretion by human axillary apoeccrine sweat gland in vitro. Am J Physiol. 1987;252:R181-R187.

121. Sato K, Timm DE, Sato F, et al. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol. 1993;75:2258-2264.

122. Schaffner R, Kreyden OP. Complications and side-effects of botulinum toxin A. Curr Probl Dermatol. 2002;30:141-148.

123. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol. 1997;136:548-552.

124. Schnider P, Moraru E, Kittler H, et al. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol. 2001;145:289-293.

125. Schnider P, Moraru E, Kittler H, Voller B, Auff E. High-dose botulinum toxin type A for axillary hyperhidrosis. Arch Dermatol. 2000;136:1567.

126. Scholes KT, Crow KD, Ellis JP, Harman RR, Saihan EM. Axillary hyperhidrosis treated with alcoholic solution of aluminium chloride hexahydrate. Br Med J. 1978;2:84-85.

127. Shachor D, Jedeikin R, Olsfanger D, Bendahan J, Sivak G, Freund U. Endoscopic transthoracic sympathectomy in the treatment of primary hyperhidrosis. A review of 290 sympathectomies. Arch Surg. 1994;129:241-244.

128. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJ. A randomised controlled trial of topical glycopyrrolate, the first specific treatment for diabetic gustatory sweating. Diabetologia. 1997;40:299-301.

129. Shen JL, Lin GS, Li WM. A new strategy of iontophoresis for hyperhidrosis. J Am Acad Dermatol. 1990;22:239-241.

130. Shrivastava SN, Singh G. Tap water iontophoresis in palmo-plantar hyperhidrosis. Br J Dermatol. 1977;96:189-195.

131. Sloan JB, Soltani K. Iontophoresis in dermatology. A review. J Am Acad Dermatol. 1986;15:671-684.

132. Solomon BA, Hayman R. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. J Am Acad Dermatol. 2000;42:1026-1029.

133. Stolman LP. Treatment of excess sweating of the palms by iontophoresis. Arch Dermatol. 1987;123:893-896.

134. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin. 1998;16:863-869.

135. Strutton DR, Kowalski J, Glaser DA, Stang P. Impact of daily activities in the US for individuals with axillary hyperhidrosis: results from a national consumer panel. Poster presentation at the Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, Calif. Poster abstract P363.

136. Strutton DR, Kowalski J, Glaser DA, Stang P. US prevalence of hyperhidrosis: results from a national consumer panel. Poster presentation at the Annual Meeting of the American Academy of Dermatology; March 21-26, 2003; San Francisco, Calif. Poster abstract P362.

137. Sung SW, Kim YT, Kim JH. Ultra-thin needle thoracoscopic surgery for hyperhidrosis with excellent cosmetic effects. Eur J Cardiothorac Surg. 2000;17:691-696.

138. Swartling C, Farnstrand C, Abt G, Stalberg E, Naver H. Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. Eur J Neurol. 2001;8:451-456.

139. Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol. 2001;8:247-252.

140. Swinehart JM. Treatment of axillary hyperhidrosis: combination of the starch-iodine test with the tumescent liposuction technique. Dermatol Surg. 2000;26:392-396.

141. Tan SR, Solish N. Long-term efficacy and quality of life in the treatment of focal hyperhidrosis with botulinum toxin A. Dermatol Surg. 2002;28:495-499.

142. Tashjian EA, Richter KJ. The value of propoxyphene hydrochloride (Darvon) for the treatment of hyperhidrosis in the spinal cord injured patient: an anecdotal experience and case reports. Paraplegia. 1985;23:349-353.

143. Telaranta T. Treatment of social phobia by endoscopic thoracic sympathicotomy. Eur J Surg. 1998;580(suppl):27-32.

144. Tkach JR. Indomethacin treatment of generalized hyperhidrosis. J Am Acad Dermatol. 1982;6:545.

145. Tögel B, Greve B, Raulin, C. Current therapeutic strategies for hyperhidrosis: a review. Eur J Dermatol. 2002;12:219-223.

146. Torch EM. Remission of facial and scalp hyperhidrosis with clonidine hydrochloride and topical aluminum chloride. South Med J. 2000;93:68-69.

147. Wang L, Hilliges M, Gajecki M, Marcusson JA, Johansson O. No change in skin innervation in patients with palmar hyperhidrosis treated with tap-water iontophoresis. Br J Dermatol. 1994;131:742-743.

148. White JW Jr. Treatment of primary hyperhidrosis. Mayo Clin Proc. 1986;61:951-956.

149. Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol. 2002;46:536-540.

150. Yamamoto H, Kanehira A, Kawamura M, Okada M, Ohkita Y. Needlescopic surgery for palmar hyperhidrosis. J Thorac Cardiovasc Surg. 2000;120:276-279.

151. Zacherl J, Huber ER, Imhof M, Plas EG, Herbst F, Fugger R. Long-term results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg. 1998;580(suppl):43-46.

152. Zacherl J, Imhof M, Huber ER, et al. Video assistance reduces complication rate of thoracoscopic sympathicotomy for hyperhidrosis. Ann Thorac Surg. 1999;68:1177-1181.

153. Naumann MK, Hamm H, Spalding JR, Kowalski JW, Lee JT. Comparing the quality of life effect of primary focal hyperhidrosis as assessed by the Dermatology Life Quality Index (DLQI). Paper presented at the July 2003 meeting of the American Academy of Dermatology; July 25-29, 2003; Chicago, Ill.

154. Hill, Samantha MD. (Fall 2010). "Hyperhidrosis Diagnosis and Management". Pediatric Rounds, a newsletter from the physicians of Children's Specialty Group, 12-14.

155. Gelbard, Christina M. MD, et al. "Primary pediatric hyperhidrosis: a review of current treatment options". Pediatric Dermatology 25:6 (2008): 591-598.

156. Ram, Ramin MD, et al. "Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures". Cosmetic Dermatology 79 (2007): 281-288.

157. Eisenach, John H. MD, et al. "Hyperhidrosis: evolving therapies for a well-established phenomenon". Mayo Clinic Proceedings 80:5 (2005): 657-666.

158. Hong, H. Chih-Ho MD, FRCPC, et al. "Clinical evaluation of a microwave device for treating axillary hyperhidrosis". Dermatol Surg doi: 10.1111/j.1524-4725.2012.02375.x. Published online March 27, 2012.

159. Lupin, Mark, et al. "A multi-center evaluation of the miradry system to treat subjects with axillary hyperhidrosis", presented at the 31st ASLMS Annual Conference, April 1-3, 2011, Grapevine, TX.

160. Glaser, Dee Anna MD, et al. "Palmar and plantar hyperhidrosis: best practice recommendations and special considerations". Cutis 79:suppl 5 (2007): 18-28.

161. Pariser, David M. MD & Ballard, Angela RN. "Iontophoresis for palmar and plantar hyperhidrosis." Dermatologic Clinics 32:4 (2014): 491-494.

Print   Email